Comprehensive knowledge-based cancer care
Location: United States, Colorado, Denver
Employees: 51-200
Total raised: $70M
Founded date: 2015
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.10.2024 | - | $45M | - |
| 21.04.2021 | Series A | $25M | - |
Mentions in press and media 11
| Date | Title | Description |
| 08.10.2024 | Navigating the Future of Oncology and Healthcare Production Amidst Challenges | In the world of healthcare, innovation is the lifeblood. Companies like VieCure and Fresenius are at the forefront, pushing boundaries and adapting to challenges. VieCure, with its recent $45 million funding, is revolutionizing community on... |
| 03.10.2024 | VieCure Secures 45M for AI-Enabled Community Oncology Care Platform | What You Should Know: – VieCure Inc., pioneer of next-generation intelligence platforms that democratize community oncology care, today announced the completion of a $45 million financing led by Northpond Ventures and the appointment of ind... |
| 02.10.2024 | VieCure Raises $45M in Financing | VieCure, a Denver, CO-based provider of an intelligence platform that aims to democratize community oncology care, raised $45M in funding. The round was led by Northpond Ventures. The company intends to use the funds to scale commercial ope... |
| 11.04.2024 | VieCure Streamlines Cancer Care with Integrated E-Prescribing and Medication Management | What You Should Know: – VieCure, a leading cancer care company, announced today that it’s integrating DrFirst’s e-prescribing and medication management solutions into its clinical decision support system. – VieCure is a well-established poi... |
| 01.06.2023 | VieCure Launches Pilot Program with Clarified Precision Medicine at ALCC to Accelerate the Adoption of Precision Oncology | With a focus on Patients and Community Oncologists, the Partners will Turn a Greater Number of Molecular Test Results Into Actionable Therapy VieCure, a cancer care company with a market-leading artificial intelligence, informatics, and cli... |
| 07.03.2023 | VieCure and Exact Sciences Enter Strategic Collaboration Aimed at Improving Patient Access to Genomic Testing | VieCure, a cancer care company with a market-leading artificial intelligence, informatics, and clinical decision support platform, announced a strategic collaboration with Exact Sciences, a leading provider of cancer screening and diagnosti... |
| 27.01.2023 | VieCure and Labcorp Collaboration Will Improve Clinical Workflow, Increasing Patient Access to Genomic Testing | Collaboration Expected to Enhance Clinical Providers’ Access to Comprehensive Genomic Testing VieCure announced a new collaboration with Labcorp to provide clinicians greater access to precision oncology decision support. This strategic col... |
| 28.07.2021 | Digital therapy: focus on results, not technology: investments, trends, new development challenges. Part 2 | Digital therapy: focus on results, not technology: investments, trends, new development challenges. Part 2 |
| 28.07.2021 | Цифровая терапия — фокус на результат, а не на технологию: инвестиции, тренды, новые вызовы развития. Часть 2 | Цифровая терапия — фокус на результат, а не на технологию: инвестиции, тренды, новые вызовы развития. Часть 2 |
| 20.04.2021 | VieCure Announces $25 Million Series A Investment Led by Northpond Ventures to Improve Oncology Care, Scale A.I. and Patient-focused Technologies | VieCure, Inc. today announced the closing of its $25 million Series A growth equity investment, led by Northpond Ventures. An undisclosed investor is also contributing to the round. VieCure, an oncology clinical informatics company with an ... |
Show more